title: New-onset acute heart failure and ventricular tachycardia after therapy with a tumor necrosis factor antagonist.
authors.forename: J F
authors.initials: JF
authors.lastname: Boyer
authors.forename: B
authors.initials: B
authors.lastname: Jamard
authors.forename: S
authors.initials: S
authors.lastname: El Mahou
authors.forename: M
authors.initials: M
authors.lastname: Laroche
authors.forename: B
authors.initials: B
authors.lastname: Mazières
authors.forename: A
authors.initials: A
authors.lastname: Cantagrel
authors.forename: A
authors.initials: A
authors.lastname: Constantin
mesh_terms: D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D017180:Tachycardia, Ventricular / Q000150:complications / Q000209:etiology* / Q000503:physiopathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab